Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Toda, H.
Right arrow Articles by Mori, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Toda, H.
Right arrow Articles by Mori, T.

Stem Cells, Vol 11, 228-234, Copyright © 1993 by AlphaMed Press


ORIGINAL ARTICLES

Therapeutic efficacy of granulocyte colony stimulating factor against rat cecal ligation and puncture model

H Toda, A Murata, N Matsuura, K Uda, Y Oka, N Tanaka and T Mori
Department of Surgery II, Osaka University Medical School, Japan.

To identify the therapeutic efficacy of granulocyte colony stimulating factor (G-CSF) in severe sepsis, we examined its effect on the mortality and pathological changes in vital organs using the rat lethal sepsis model. Rats were given 15 micrograms of recombinant human (rh)G- CSF after the onset of peritonitis brought about by cecal ligation and puncture. The mortality rate after 72 h was significantly decreased by administration of 15 micrograms of rhG-CSF (p < 0.001). In addition, the administration of rhG-CSF induced an improvement in liver and renal functions. It also produced marked pathological improvement in the lungs. These results strongly indicated that administration of rhG-CSF, even after the onset of sepsis, was effective in decreasing the mortality from peritonitis-induced multiple organ failure, and this finding was clearly useful in the clinical treatment of such sepsis- induced critical illness.


This article has been cited by other articles:


Home page
Clin. Microbiol. Rev.Home page
A. C. Cheng and B. J. Currie
Melioidosis: Epidemiology, Pathophysiology, and Management
Clin. Microbiol. Rev., April 1, 2005; 18(2): 383 - 416.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
K. Rodgers, S. Xiong, T. Espinoza, N. Roda, S. Maldonado, and G. S. diZerega
Angiotensin II Increases Host Resistance to Peritonitis
Clin. Vaccine Immunol., July 1, 2000; 7(4): 635 - 640.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.peprotech.com/
Copyright © 1993 by AlphaMed Press.